姓名：黄海荣 性别：女 职称：研究员、教授 招生院所：胸科医院 招生类型：科学学位(博) 科学学位(硕) 招生专业：病原生物学(博) 病原生物学(硕) 研究方向名称：结核病细菌学 电子信箱：nclhuang@ccmu.edu.cn


社会任职
1. 中国防痨协第十一届结核病学术工作委员会
2. 中华医学会结核病学分会基础委员会委员
3. 北京医学会结核病分会常务委员
4. 中国医疗保健国际交流促进性结核病防治分会第一届委员会基础学组委员
5. 中国防痨协会第十一届结核病基础专业分会常务委员
6. 中国医疗保健国际交流促进会分子诊断委员会常务委员
7. 中华医学会结核病学分会分基础研究专业委员会主任委员
8. 中华医学会结核病学分会基础学组副组长
9. 中国防痨协会基础专业分会副主任委员
10. 世界卫生组织体外诊断策略咨询委员会专家
11. BMC Infectious Disease杂志副主编
个人简历
1. 199009-199507:河南医科大学 学士
2. 199509-199807:河南医科大学 硕士
3. 199809-200107:北京市结核病胸部肿瘤研究所 博士
4. 200107-200206:北京市结核病胸部肿瘤研究所 助理研究员
5. 200206-200604:美国科罗拉多州立大学 博士后
6. 200605-200611:北京市结核病胸部肿瘤研究所 助理研究员
7. 200611-201110:北京市结核病胸部肿瘤研究所 副研究员
8. 201111-201602:北京市结核病胸部肿瘤研究所 研究员
重要学术论文
1. Wang G, Wang S, Yang X, Sun Q, Jiang G, Huang M, Huo F, Ma Y, Chen X*, Huang H*.Accuracy of Xpert MTB/RIF Ultra for the diagnosis of pleural tuberculosis in a multicentre cohort study.. Chest. 2020,157(2):268-275.SCI
2. Jing W, Zong Z,Tang H,Wang J,Zhang T, Wen S,Xue Y,Chu N*,Zhao W*, Huang H*.Population Pharmacokinetic Analysis of Isoniazid among Pulmonary Tuberculosis Patients from China.. Antimicrob Agents Chemother. 2020,64(3):-.SCI
3. Huang H#, Ding N#, Yang T#, Li C#, Jia X#, Wang G#, Zhong J, Zhang J, Jiang G, Wang S, Zong Z, Jing W, Zhao Y, Xu S*, Chen F*.Cross-sectional whole-genome sequencing and epidemiological study of multidrug-resistant Mycobacterium tuberculosis in China.. Clin Infect Dis. 2019,65:405-413.SCI
4. Dai G#, Chen S#, Dong L,Huo F, Shang Y,Huang H*.Determination of the critical concentration of rifabutin for susceptibility testing using the proportion method with Löwenstein-Jensen medium against Mycobacterium tuberculosis isolates.. Lab Medicine. 2019,50(3):292-297.SCI
5. Sun L, Zhang L, Wang T, Jiao W, Li Q, Yin Q, Li J, Qi H, Xu F, Shen C, Xiao J, Liu S, Mokrousov I*, Huang H*, Shen A*. Mutations of Mycobacterium tuberculosis induced by anti-tuberculosis treatment result in metabolism changes and elevation of ethambutol resistance.. Infect Genet Evol. 2019,72:151-158.SCI
6. Zhang T, Jiang G, Wen S, Huo F, Wang F, Huang H*, Pang Y*. Para-aminosalicylic acid increases the susceptibility to isoniazid in clinical isolates of Mycobacterium tuberculosis. . Infect Drug Resist. 2019,12:825-829.SCI
7. Jiao W, Wang Y, Wang G, Wang Y, Xiao Jing, Sun L, Li J, Wen S, Zhang T,Ma Q, Huang H*, Shen A*..Development and clinical validation of multiple cross displacement amplification combined with nanoparticles-based biosensor for detection of Mycobacterium tuberculosis: preliminary results.. Front Microbiol. . 2019,-:-.SCI
8. Sun Q, Wang S, Dong W, Jiang G, Huo F, Ma Y, Huang H*, Wang G*. Diagnostic value of Xpert MTB/RIF Ultra for osteoarticular tuberculosis. . J Infect. . 2019,79(2):153-158.SCI
9. Yu X, Gao X, Li C, Luo J,Wen S ,Zhang Z, Ma Y,Dong L,Wang F, Huang H*.In Vitro Activity of bedaquiline and delamanid against Non-tuberculous Mycobacteria isolated in Beijing, China.. AAC. 2019,63(8):-.SCI
10. Pang Y, Jing W, Lu J, Zong Z, Huo F, Dong L, Dai G, Li Y, Huang H*, Chu N*.No in vitro synergistic effect of bedaquiline combined with fluoroquinolones, linezolid, and clofazimine against extensively drug-resistant tuberculosis.. Diagn Microbiol Infect Dis.. 2019,94(4):361-364.SCI
11. Liu R, Liang Q, Shang Y, Ma Y, Wang F, Dong L, Huang H*, Gao M*, Pang Y*.GeneXpert of stool versus gastric lavage fluid for the diagnosis of pulmonary tuberculosis in severely ill adults.. Infection. 2019,47(4):611-616.SCI
12. Wang G#, Wang S#, Jiang G#, Yang X#,Huang M, Huo F,Ma Y, Dai G, Li W, Chen X*, Huang H*.Xpert MTB/RIF Ultra improved the diagnosis of paucibacillary tuberculosis: a prospective cohort study. . J Infect. 2019,78(4):311-316.SCI
13. Wen S, Jing W, Zhang T, Zong Z, Xue Y, Shang Y, Wang F, Huang H*, Chu N*, Pang Y*.Comparison of in vitro activity of the nitroimidazoles delamanid and pretomanid against multidrug-resistant and extensively drug-resistant tuberculosis.. Eur J Clin Microbiol Infect Dis. 2019,38(7):1293-1296.SCI
14. Wang Q, Pang Y, Jing W， Liu Y, Wang N, Yin H, Zhang Q, Ye Z, Zhu, M, Li M, Liu P, Wu T, Chen C, Wu W, Qin Z, Qiu C, Deng Q, Xu T, Wang J, Guo R, Du Y, Wang J, Huang H*, Chen X, Chu N. Clofazimine for Treatment of Pulmonary Extensively Drug-Resistant Tuberculosis in China . Antimicrob Agents Chemother. 2018, : .SCI
15. Wang G, Wang S, Jiang G, Fu Y, Shang S, Huang H* . Incremental cost-effectiveness of the second Xpert MTB/RIF assay to detect Mycobacterium tuberculosis . Journal of Thoracic Disease . 2018,10(3):1689-1695 .SCI
16. Wu X, Pang Y, Song Y, Dong W, Zhang T, Wen S, Huang H*, Gao M* . Implications of a school outbreak of multidrug-resistant tuberculosis in Northern China . Epidemiol Infect . 2018,146(5):584-588 .SCI
17. Xia Yu#, Xiling Zeng#, Wenhui Shi, Yanjie Hu, Wenjuan Nie, Naihui Chu*, Huang H*.Validation of Cycloserine Efficacy in Treatment of Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis in Beijing, China. Antimicrob Agents Chemother . 2018,62(3) : .SCI
18. Luo J#,Yu X#, Jiang G, Fu Y, Huo F, Ma Y,Wang F, Shang Y, Liang Q, Xue Y, Huang H*.In Vitro Activity of Clofazimine against Nontuberculous Mycobacteria in China. Antimicrob. Antimicrob. Agents Chemother. 2018,62（7）:-.SCI
19. Zong Z#, Jing W#, Shi J, Wen S, Zhang T, Huo F, Shang Y, Liang Q, Huang H*, Pang Y*. .Comparison of in vitro activity and MIC distributions between the novel oxazolidinone delpazolid and linezolid against multidrug-resistant and extensively drug-resistant Mycobacterium tuberculosis in China. . Antimicrob Agents Chemother. 2018,62(8):-.SCI
20. Shi J#, Dong W#, Ma Y, Liang Q, Shang Y, Wang F, Huang H*, Pang Y*..GeneXpert MTB/RIF Outperforms Mycobacterial Culture in Detecting Mycobacterium tuberculosis from Salivary Sputum. . Biomed Res Int. 2018,-:-.SCI
21. Shi J#, Lu J#, Wen S, Zong Z, Huo F, Luo J, Liang Q, Li Y, Huang H*, Pang Y*. .In vitro activity of PBTZ169 against multiple Mycobacterium species. . Antimicrob Agents Chemother. 2018,62(11):-.SCI
22. Zong Z#, Huo F#, Shi J, Jing W, Ma Y, Liang Q, Jiang G, Dai G, Huang H*, Pang Y*.. Relapse Versus Reinfection of Recurrent Tuberculosis Patients in a National TuberculosisSpecialized Hospital in Beijing, China.. Front Microbiol.. 2018,9:-.SCI
23. Yang T#,Zhong J#, Zhang J#, Li C, Yu X, Xiao J, Jia X, Ding N, Ma G, Wang G,Yue L, Liang Q, Sheng Y, Sun Y, Huang H*, Chen F*.Pan-genomic study of Mycobacterium tuberculosis reflecting the primary/secondary genes, generality/individuality, and the interconversion through copy number variations. Frontiers in Microbiology. 2018,10:-.SCI
24. Wang G#, Dong W#, Lan T, Fan J,Tang K, Li Y,Yan G,Jiang G, Ma Y, Shang Y, Qin S*, Huang H*.Diagnostic accuracy evaluation of the conventional and molecular tests for Spinal Tuberculosis in a cohort, head-to-head study. . Emerging Microbes & Infections. 2018,7(1):109-117.SCI
25. Huo F, Luo J, Shi J, Zong Z, Wei Jing, Wenzhu Dong,Lingling Dong,Yifeng Ma, Qian Liang,Yuanyuan Shang, Huang H*, Yu Pang . Increasing Prevalence of Rifampicin-Resistant Mycobacterium tuberculosis is Associated with the Transmission of Strains Harboring Compensatory Mutations in China: A 10-year Comparative Analysis . Antimicrob Agents Chemother . 2018,62(4) : .SCI
26. Tan J#,Wu X#,Chen S,Gu M, Huang H*,Yue W* .Dominant epitopes derived from cell-wall protein LppZ for immunodiagnostic ofpulmonary tuberculosis. BMC Immunology . 2018,19(1):10.SCI
27. Jing W#, Pang Y#, Zong Z, Wang J, Guo R, Huo F, Jiang G, Ma Y, Huang H*, Chu N*.Rifabutin Resistance Associated with Double Mutations in rpoB Gene in Mycobacterium tuberculosis Isolates. Front Microbiol. 2017,8:1768.SCI
28. Pang Y#, Lu J, Huo F, Ma Y, Zhao L, Li Y, Liang Q, Chu N, Gao M, Huang H*.Prevalence and treatment outcome of extensively drug-resistant tuberculosis plus additional drug resistance from the National Clinical Center for Tuberculosis in China: A five-year review. J Infect. 2017,75(5):433-440.SCI
29. Li H,Wang X,Wang B,Fu L,Liu G,Lu Y,Cao M,Huang H*, Javid B*.Latently and uninfected healthcare workers exposed to tuberculosis make protective antibodies against Mycobacterium tuberculosis. PNAS. 2017, : .SCI
30. Chen S,Han Y,Yu D,Huo F,Wang F,Li Y,Dong L,Liu Z,Huang H*.Transdermal delivery of isoniazid and rifampin in guinea pigs by electro-phonophoresis. Drug Deliv. 2017,24:1:467-470.SCI
31. Jia X, Yang L, Dong M, Chen S, Lv L, Cao D,Fu J, Yang J, Zhang J, Zhang X, Shang Y, Wang G, Sheng Y, Huang H*, Chen F.The bioinformatics analysis of comparative genomics of Mycobacterium tuberculosis complex (MTBC) provides insight into dissimilarities between intraspecific groups differing in host association, virulence and epitope diversity. Frontiers in Cellular and Infection Microbiology. 2017,7:88.SCI
32. Pang Y#, Shang Y#, Lu J, Liang Q, Dong L, Li Y, Zhao L, Jiang G, Huang H*.GeneXpert MTB/RIF assay in the diagnosis of urinary tuberculosis from urine specimens. Scientific reports. 2017,7(1):6181.SCI
33. Pang Y#, Zong Z#, Huo F, Jing W, Ma Y, Dong L, Li Y, Zhao L, Fu Y, Huang H*.In vitro drug susceptibility of bedaquiline, delamanid, linezolid, clofazimine, moxifloxacin, and gatifloxacin against extensively drug –resistant tuberculosis from Beijing, China. Antimicrob Agents Chemother. 2017,61(10): .SCI
34. Zeng X, Jing W, Zhang Y, Duan H, Lu Y, Dong Q, Huang H*, Chu N*.Performance of the MTBDRsl Line probe assay for rapid detection of resistance to second-line anti-tuberculosis drugs and ethambutol in China. . Diagn Microbiol Infect Dis. 2017,89(2):112-117.SCI
35. Chen H#, He L#, Huang H#, Shi C, Ni X, Dai G, Ma L, Li W.Mycobactrium tuberculosis Lineage Distribution in Xinjiang and Gansu Provinces, China.. Sci Rep. 2017,7(1):1068.SCI
36. Li QJ, Jiao WW, Yin QQ, Li YJ, Li JQ, Xu F, Sun L, Xiao J, Qi H, Wang T, Mokrousov I, Huang H*, Shen AD*.Positive epistasis of major low-cost drug resistance mutations rpoB531-TTG and katG315-ACC depends on the phylogenetic background of mycobacterium tuberculosis strains.. Int J Antimicrob Agents. 2017,-:-.SCI
37. Chen S#, Qin M#, Han Y, Zhao L, Fu Y, Shang Y, Liu Z, Huang H*.Assessment of the efficacy of drug transdermal delivery by electro-phonophoresis in treating tuberculous lymphadenitis.. Drug Deliv. 2016,23(5):-.SCI
38. Duan H,Han X, Wang Q,Wang J,Wang J,Chu N,Huang H*.Clinical Significance of Nontuberculous Mycobacteria Isolated From Respiratory Specimens in a Chinese Tuberculosis Tertiary Care Center. Scientific Reports. 2016,6:36299.SCI
39. Wei G,Mu J,Wang G,Huo F,Dong L,Li Y, Huang H*.Evaluation of Xpert positive but smear negative culture-negative outcomes for tuberculosis diagnosis. Journal of Thoracic Disease. 2016,8(6):1205-9.SCI
40. Yin QQ, Jiao WW, Li QJ, Xu F, Li JQ, Sun L, Li YJ, Huang HR*, Shen AD*.Prevalence and molecular characteristics of drug-resistant Mycobacterium tuberculosis in Beijing, China: 2006 versus 2012. BMC Microbiol. 2016,16 (1):85.SCI
41. Zeng X, Jing W, Zhang Y, Duan H, Lu Y, Dong Q, Huang H*, Chu N*.Performance of the MTBDRsl Line probe assay for rapid detection of resistance to second-line anti-tuberculosis drugs and ethambutol in China. Diagn Microbiol Infect Dis. 2016,(16):30171-7.SCI
42. Hu Y, Chen S, Yu X, Dai G, Dong L, Li Y, Zhao L, Huang H*.Rapid identification of the NAT2 genotype in tuberculosis patients by multicolor melting curve analysis. Pharmacogenomics. 2016,60(5):1211-5.SCI
43. Yu X, Gu Y, Jiang G, Ma Y, Zhao L, Sun Z, Jain P, O'Donnell M, Larsen M, Jacobs WR Jr, Huang H*.Evaluation of a High-Intensity Green Fluorescent Protein Fluorophage Method for Drug- Resistance Diagnosis in Tuberculosis for Isoniazid, Rifampin, and Streptomycin. Front Microbiol. 2016,7:922.SCI
44. Li QJ, Jiao WW, Yin QQ, Xu F, Li JQ, Sun L, Xiao J, Li YJ, Mokrousov I, Huang HR*, Shen AD*.Compensatory Mutations of Rifampicin Resistance Are Associated with Transmission of Multidrug Resistant Mycobacterium tuberculosis Beijing genotype strains in China. Antimicrob Agents Chemother. 2016,60(5):2807-12.SCI
45. Xie L#, Wang G#, Yu Z, Zhou M, Li Q, Huang H*, Xie J*.Proteome-wide Lysine Glutarylation Profiling of the Mycobacterium tuberculosis H37Rv. J Proteome Res. 2016,15(4):1379-85.SCI
46. Zhang L,Pang Y,Yu X,Wang Y,Gao M,Huang H*,Zhao Y.Risk factors for pulmonary cavitation in tuberculosis patients from China. Emerging Microbes & Infections. 2016,5:111.SCI
47. Wang G, Yang X, Zhu J, Dong W, Huang M, Jiang G, Zhao L, Qin S, Chen X, Huang H*.Evaluation of the efficacy of Myco/F lytic system, MGIT960 system and Lowenstein-Jensen medium for recovery of Mycobacterium tuberculosis from sterile body fluids. Scientific Reports. 2016,6:37757.SCI
48. Yu X, Ma Y, Jiang G, Chen S,Wang G, Huang H*.Evaluation of the Sensititre MYCOTB Plate for Susceptibility Testing of the Mycobacterium tuberculosis Complex Isolates. IJTL. 2016,20(3):329-334.SCI
49. Gu Y#,Yu X#,Jiang G,Wang X,Ma Y,Li Y, Huang H*.Pyrazinamide resistance among multidrug-resistant tuberculosis clinical isolates in a national referral center of China and its correlations with pncA, rpsA and panD gene mutations. Diagn Microbiol Infect Dis.. 2016,84:207-211.SCI
50. Lingxiang Zhu#,Jun Zhong#,Xinmiao Jia#,Guan Liu#,Yu Kang#,Mengxing Dong,Xiuli Zhang,Qian Li,Liya Yue,Cuidan Li, Jing Fu,Jingfa Xiao,Jiangwei Yan,Bing Zhang,Meng Lei,Suting Chen,Lingna Lv,Baoli Zhu,Hairong Huang*, Fei Chen*.Precision methylome characterization of Mycobacterium tuberculosis complex (MTBC) using PacBio single-molecule real-time (SMRT) technology. Nucleic Acids Research. 2016,44(2):730-743.SCI
51. Li XY, Li Y, Zhang Y, Kang WL, Zhao LP, Ding PJ, Dai WT, Huang HR*, Huang YF*, Li WM*.The Epidemiological Characteristics of Beijing Lineage Mycobacterium tuberculosis from a National Referral Center in China. Biomed Environ Sci. 2015,28(7):539-43..SCI
52. Wei G,Huang M,Wang G,Huang H*.Antimicrobial Susceptibility Testing and Genotyping of Mycobacterium avium isolates of Two Tertiary Tuberculosis designated Hospital, China. Infect Genet Evol. 2015,36:141-146.SCI
53. Yu X, Zhao L,Jiang G,Ma Y, Li W,Huang H*.Macrocolonies (granules) formation as a cause of false-negative results in the MGIT 960 System. Cause analysis and correlation with Mycobacterial species. BioMed Res Int. 2015, :501874.SCI
54. Zhang X#, Liu L#, Zhang Y#,Dai G, Huang H* , Jin Q*.Genetic Determinants Involved in p-Aminosalicylic Acid Resistance in Clinical Isolates from Tuberculosis Patients in Northern China from 2006 to 2012. Antimicrobial Agents and Chemotherapy. 2015,59(2):1320-1324.SCI
55. Li H#, Kayani MU#, Gu Y#, Wang X, Zhu T, Duan H, Ma Y, Huang H*, Javid B*.Transmitted Extended-Spectrum Extensively Drug-Resistant Tuberculosis in Beijing, China, with Discordant Whole-Genome Sequencing Analysis Results. J Clin Microbiol. 2015,53(8):2781-4.SCI
56. Liu Guan#, Chen Suting#, Yu Xia, Li Yunxu, Ling Ying, Dong Lingling, Zheng Suhua*, Huang Hairong*.Bacteriological and virulence study of a Mycobacterium Chimaera isolate from a patient in China. Antonie Van Leeuwenhoek. 2015,107(4):901-909.SCI
57. Li X#, Chen L#, Zhu Y, Yu X, Cao J, Wang R,Lv X,He J,Guo A,Huang H*,Zheng H*,Liu S*.Genomic Analysis of a Mycobacterium Bovis bacillus Calmette-Guérin Strain Isolated from an Adult Patient with Pulmonary Tuberculosis. Plos One. 2015,10(4):e**.SCI
58. Nie W,Duan H,Huang H*,Lu Y,Chu N*. Species Identification and Clarithromycin Susceptibility Testing of 278 Clinical Nontuberculosis Mycobacteria Isolates. BioMed Res Int. 2015,6:506598.SCI
59. Chen S, Zhao L, Dong W, Gu Y, Li Y, Dong L, Ma Y, Qin S, Huang H*.The Clinical Features and Bacteriological Characterizations of Bone and Joint Tuberculosis in China. Sci Rep.. 2015,5:11084.SCI
60. Gu Y#,Wang G#,Dong W,Li Y,Ma Y,Shang Y,Qin S*,Huang H*. Xpert MTB/RIF and GenoType MTBDRplus assay for Rapid Diagnosis of Bone and Joint Tuberculous. International journal of infectious diseases. Int J Infect Dis. . 2015,36:27-30.SCI
61. Chen S#, Qin M#, Han Y, Zhao L, Fu Y, Shang Y, Liu Z, Huang H*.Assessment of the efficacy of drug transdermal delivery by electro-phonophoresis in treating tuberculous lymphadenitis.. Drug Deliv. 2015,22(8):1-6.SCI
62. Jiang, G#. Wang G#,Cheng S,Yu X,Wang X,Zhao L,Ma Y,Dong L,Huang H*.Pulmonary Tuberculosis Caused by Mycobacterium bovis in China. Sci. Rep.. 2015,5:1-3.SCI
63. Zhang L#, Pang Y#, Yu X#, Wang Y, Gao M*, Huang H* ,Zhao Y*.Linezolid in the treatment of extensively drug-resistant tuberculosis. . Infection. 2014,42(4):705-11..SCI
64. Liu Guan#, Chen Suting#, Yu Xia, Li Yunxu, Ling Ying, Dong Lingling, Zheng Suhua*, Huang Hairong* .Bacteriological characterization of a Mycobacterium parascrofulaceum strain isolated from a Chinese pneumonia patient. . Int J Infect Dis. . 2014,25:82-87.SCI
65. Wang X, Zhao L, Yu X, Li Y, Ma Y, Dong L, Huang H*.Bead capture increases the sensitivity of sputum microscopy for the diagnosis of tuberculosis in Beijing, China.. T ROY SOC TROP MED H. 2013,107(11):741-743.SCI
66. Long Q,Li W,Du Q, Fu Y,Liang Q, Huang H*,Xie J*.GyrA/B fluoroquinolone-resistant allele profiles among Mycobacterium tuberculosis isolates from Mainland China.. International Journal of Antimicrobial Agents. 2012,39(6）:486-489.SCI
67. Yu X, Jiang G, Li H, Zhao Y, Zhang H, Zhao L, Ma Y, Coulter C, Huang H*..Rifampicin stability in 7H9 broth and Lowenstein-Jensen medium.. Journal of Clinical Microbiology. 2011,48(3):0095-1137.SCI
68. Huang H, Berg S, Spencer J, Vereecke D, D’Haeze D, Holsters M, McNeil M*..Identification of cytoplasmic and transmembrane domains required for catalytic activity of 5-phospho-D-ribose-1-diphosphate: decaprenyl-phosphate 5-phosphoribosyltransferase. Microbiol-SGM. 2008,154(3):736-743.SCI
69. Huang H, Scherman MS, D'Haeze W, Vereecke D, Holsters M, Crick DC, McNeil MR*.Identification and active expression of the Mycobacterium tuberculosis gene encoding 5-phospho-{alpha}-d-ribose-1-diphosphate: decaprenyl-phosphate 5-phosphoribosyltransferase, the first enzyme committed to decaprenylphosphoryl-d-arabinose synthesis. . J Biol Chem. . 2005,280(26):24539-43.SCI
70. Mikusova K, Huang H, Yagi T, Holsters M, Vereecke D, D'Haeze W, Scherman MS, Brennan PJ, McNeil MR, Crick DC.. Decaprenylphosphoryl arabinofuranose, the donor of the D-arabinofuranosyl residues of mycobacterial arabinan, is formed via a two-step epimerization of decaprenylphosphoryl ribose.. J Bacteriol.. 2005,187(23):8020-8025.SCI
主编或副主编的著作/译著
1. 《结核病实验室标准化操作教程》,副主编,中华医学电子音像出版社 ,201209
重要奖项
1. 结核病诊疗关键技术的创新性研究与应用 北京市科技进步奖 二等奖 201412
2. 结核病防控新措施的基础研究 重庆市科学技术奖 三等奖 2014
3. 结核病的快速基因诊断及耐药分子机制的研究 北京市科技进步奖 三等奖 200110